NO990722L - Fremgangsmåte for behandling av hjertesvikt - Google Patents

Fremgangsmåte for behandling av hjertesvikt

Info

Publication number
NO990722L
NO990722L NO990722A NO990722A NO990722L NO 990722 L NO990722 L NO 990722L NO 990722 A NO990722 A NO 990722A NO 990722 A NO990722 A NO 990722A NO 990722 L NO990722 L NO 990722L
Authority
NO
Norway
Prior art keywords
heart failure
treatment
procedure
phenoxy
trimethyl
Prior art date
Application number
NO990722A
Other languages
English (en)
Norwegian (no)
Other versions
NO990722D0 (no
Inventor
Yuhpyng Liang Chen
Anthony Andrea Fossa
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO990722D0 publication Critical patent/NO990722D0/no
Publication of NO990722L publication Critical patent/NO990722L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO990722A 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt NO990722L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (2)

Publication Number Publication Date
NO990722D0 NO990722D0 (no) 1999-02-16
NO990722L true NO990722L (no) 1999-08-18

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990722A NO990722L (no) 1998-02-17 1999-02-16 Fremgangsmåte for behandling av hjertesvikt

Country Status (28)

Country Link
US (1) US6043260A (fr)
EP (1) EP0951906A1 (fr)
JP (1) JPH11292766A (fr)
KR (1) KR19990072616A (fr)
CN (1) CN1231176A (fr)
AP (1) AP9901464A0 (fr)
AR (1) AR017723A1 (fr)
AU (1) AU1732999A (fr)
BG (1) BG103180A (fr)
BR (1) BR9900653A (fr)
CA (1) CA2262252C (fr)
EA (1) EA199900124A3 (fr)
GT (1) GT199900015A (fr)
HR (1) HRP990054A2 (fr)
HU (1) HUP9900386A3 (fr)
ID (1) ID23218A (fr)
IL (1) IL128531A0 (fr)
IS (1) IS4975A (fr)
MA (1) MA26608A1 (fr)
NO (1) NO990722L (fr)
OA (1) OA10976A (fr)
PA (1) PA8467401A1 (fr)
PE (1) PE20000266A1 (fr)
PL (1) PL331507A1 (fr)
SG (1) SG81261A1 (fr)
TN (1) TNSN99024A1 (fr)
TR (1) TR199900328A2 (fr)
ZA (1) ZA991220B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
AU7604400A (en) 1999-09-21 2001-04-24 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
KR20020063934A (ko) * 2000-01-18 2002-08-07 화이자 프로덕츠 인코포레이티드 코르티코트로핀 방출 인자 길항제
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US7015229B2 (en) 2002-02-22 2006-03-21 Pfizer Inc Substituted pyrimidinones and pyrimidinthiones
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
JP2005533014A (ja) * 2002-04-26 2005-11-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換ピラジン誘導体
JP2006506350A (ja) * 2002-09-12 2006-02-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 置換１，４−ピラジン誘導体
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
EP1565454A1 (fr) * 2002-11-21 2005-08-24 Pharmacia & Upjohn Company LLC Composes de pyrazine en tant que modulateurs de crf
BRPI0409649A (pt) * 2003-04-23 2006-04-25 Pharmacia & Upjohn Co Llc pirimidinonas e pirimidinotionas substituìdas como antagonistas de crf
MXPA05011993A (es) * 2003-05-07 2006-02-02 Pharmacia & Upjohn Co Llc Compuestos de pirrolo[1,2-b]piridazina.
EP1625125A1 (fr) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Composes utilises comme antagonistes du recepteur de type 1 de la corticoliberine (crf)
MXPA05012081A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Derivados de pirimidina sustituidos.
EP1626965A1 (fr) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Company LLC Pyrazinones a titre d'antagonistes du recepteur de crf1 dans le traitement des troubles du systeme nerveux central
WO2005089639A2 (fr) * 2004-03-16 2005-09-29 Talarico M D Matthew T Procede de deregulation vasculaire
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (fr) * 1996-03-13 1997-09-17 Pfizer Inc. Utilisation de l'amlodipine pour le traitement et la prophylaxie de l'insuffisance cardiaque congestive d'origine non-ischémique

Also Published As

Publication number Publication date
PL331507A1 (en) 1999-08-30
IL128531A0 (en) 2000-01-31
ID23218A (id) 2000-03-30
AR017723A1 (es) 2001-09-12
IS4975A (is) 1999-08-18
BG103180A (bg) 1999-09-30
AU1732999A (en) 1999-09-02
PA8467401A1 (es) 2000-09-29
SG81261A1 (en) 2001-06-19
PE20000266A1 (es) 2000-04-07
TR199900328A2 (xx) 1999-10-21
BR9900653A (pt) 2000-10-17
CA2262252C (fr) 2006-01-10
TNSN99024A1 (fr) 2005-11-10
HRP990054A2 (en) 2000-02-29
JPH11292766A (ja) 1999-10-26
HUP9900386A2 (hu) 1999-11-29
AP9901464A0 (en) 1999-03-31
ZA991220B (en) 2000-08-16
NO990722D0 (no) 1999-02-16
CA2262252A1 (fr) 1999-08-17
HU9900386D0 (en) 1999-04-28
KR19990072616A (ko) 1999-09-27
EA199900124A2 (ru) 1999-08-26
EA199900124A3 (ru) 1999-12-29
US6043260A (en) 2000-03-28
EP0951906A1 (fr) 1999-10-27
MA26608A1 (fr) 2004-12-20
HUP9900386A3 (en) 1999-12-28
CN1231176A (zh) 1999-10-13
GT199900015A (es) 2000-07-26
OA10976A (en) 2001-11-05

Similar Documents

Publication Publication Date Title
NO990722L (no) Fremgangsmåte for behandling av hjertesvikt
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
DK0923570T3 (da) Pyridylalken- og pyridylalkynsyreamider som cytostatiske og immunosuppresive midler
DK1107794T3 (da) Terapeutiske præparater til behandling af mucus-hypersekretion
NO962130L (no) Synergistisk behandling av Parkinsons sykdom
EA200401160A1 (ru) Производные тиазола и оксазола, которые модулируют активность ppar
BR9811099A (pt) Inibidores de urocinase
ATE273279T1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
EA200301276A1 (ru) Новые производные сульфоновых кислот
DK0888271T3 (da) Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler
FI103111B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
NO305517B1 (no) Silylerte acetylcholinesteraseinhibitorer, og farmas°ytisk preparat inneholdende disse
AU551066B2 (en) Pyridyl substituted pyridylalkyleneamino pyrimidones
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
EA199800889A1 (ru) Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция
EA200101205A1 (ru) Применение комбинации витаминов для лечения зуда и неинфекционных заболеваний, приводящих к зуду и/или воспалению
DE69829861D1 (de) 2-aminopyridine als inhibitoren von cyclooxygenase-2
DK1152760T3 (da) Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
NO20051390L (no) Fremgangsmate for behandling av pasienter med massivt blodtap
EE04658B1 (et) Pridasinooni derivaadi uus kasutusv?imalus
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain